Literature DB >> 25020101

Bacterial foodborne infections after hematopoietic cell transplantation.

Nicole M Boyle1, Sara Podczervinski2, Kim Jordan2, Zach Stednick1, Susan Butler-Wu3, Kerry McMillen2, Steven A Pergam4.   

Abstract

Diarrhea, abdominal pain, and fever are common among patients undergoing hematopoietic cell transplantation (HCT), but such symptoms are also typical with foodborne infections. The burden of disease caused by foodborne infections in patients undergoing HCT is unknown. We sought to describe bacterial foodborne infection incidence after transplantation within a single-center population of HCT recipients. All HCT recipients who underwent transplantation from 2001 through 2011 at the Fred Hutchinson Cancer Research Center in Seattle, Washington were followed for 1 year after transplantation. Data were collected retrospectively using center databases, which include information from transplantation, on-site examinations, outside records, and collected laboratory data. Patients were considered to have a bacterial foodborne infection if Campylobacter jejuni/coli, Listeria monocytogenes, E. coli O157:H7, Salmonella species, Shigella species, Vibrio species, or Yersinia species were isolated in culture within 1 year after transplantation. Nonfoodborne infections with these agents and patients with pre-existing bacterial foodborne infection (within 30 days of transplantation) were excluded from analyses. A total of 12 of 4069 (.3%) patients developed a bacterial foodborne infection within 1 year after transplantation. Patients with infections had a median age at transplantation of 50.5 years (interquartile range [IQR], 35 to 57), and the majority were adults ≥18 years of age (9 of 12 [75%]), male gender (8 of 12 [67%]) and had allogeneic transplantation (8 of 12 [67%]). Infectious episodes occurred at an incidence rate of 1.0 per 100,000 patient-days (95% confidence interval, .5 to 1.7) and at a median of 50.5 days after transplantation (IQR, 26 to 58.5). The most frequent pathogen detected was C. jejuni/coli (5 of 12 [42%]) followed by Yersinia (3 of 12 [25%]), although Salmonella (2 of 12 [17%]) and Listeria (2 of 12 [17%]) showed equal frequencies; no cases of Shigella, Vibrio, or E. coli O157:H7 were detected. Most patients were diagnosed via stool (8 of 12 [67%]), fewer through blood (2 of 12 [17%]), 1 via both stool and blood simultaneously, and 1 through urine. Mortality due to bacterial foodborne infection was not observed during follow-up. Our large single-center study indicates that common bacterial foodborne infections were a rare complication after HCT, and the few cases that did occur resolved without complications. These data provide important baseline incidence for future studies evaluating dietary interventions for HCT patients.
Copyright © 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteria; Campylobacter; Diet; Foodborne; Hematopoietic; Transplantation

Mesh:

Year:  2014        PMID: 25020101      PMCID: PMC4194273          DOI: 10.1016/j.bbmt.2014.06.034

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  35 in total

1.  Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.

Authors:  Carles Ubeda; Ying Taur; Robert R Jenq; Michele J Equinda; Tammy Son; Miriam Samstein; Agnes Viale; Nicholas D Socci; Marcel R M van den Brink; Mini Kamboj; Eric G Pamer
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

2.  Campylobacter jejuni cutaneous infection in a patient with graft versus host disease.

Authors:  A Bousquet; T Demoures; J-V Malfuson; C Martinaud; C Soler
Journal:  Med Mal Infect       Date:  2012-05-15       Impact factor: 2.152

Review 3.  Bone-marrow transplantation (second of two parts).

Authors:  E D Thomas; R Storb; R A Clift; A Fefer; L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-24       Impact factor: 91.245

Review 4.  Listeriosis: a resurgent foodborne infection.

Authors:  F Allerberger; M Wagner
Journal:  Clin Microbiol Infect       Date:  2010-01       Impact factor: 8.067

Review 5.  Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation.

Authors:  Steven M Trifilio; Judy Pi; Jayesh Mehta
Journal:  Biol Blood Marrow Transplant       Date:  2012-12-04       Impact factor: 5.742

6.  Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation.

Authors:  Stefan Schwartz; Maria Vergoulidou; Eckart Schreier; Christoph Loddenkemper; Mark Reinwald; Martin Schmidt-Hieber; Willy A Flegel; Eckhard Thiel; Thomas Schneider
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

7.  Vibrio vulnificus bacteremia associated with chronic lymphocytic leukemia, hypogammaglobulinemia, and hepatic cirrhosis: relation to host and exposure factors in 252 V. vulnificus infections reported in Louisiana.

Authors:  James C Barton; Raoult C Ratard
Journal:  Am J Med Sci       Date:  2006-10       Impact factor: 2.378

8.  The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.

Authors:  Marilyn J Hammer; Corey Casper; Ted A Gooley; Paul V O'Donnell; Michael Boeckh; Irl B Hirsch
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

9.  One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation.

Authors:  Veronique Erard; Katherine A Guthrie; Cara Varley; Judson Heugel; Anna Wald; Mary E D Flowers; Lawrence Corey; Michael Boeckh
Journal:  Blood       Date:  2007-05-21       Impact factor: 22.113

10.  Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.

Authors:  Sara C Meyer; Alix O'Meara; Andreas S Buser; André Tichelli; Jakob R Passweg; Martin Stern
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-23       Impact factor: 5.742

View more
  2 in total

1.  Diarrheal Morbidity During Hematopoietic Cell Transplantation: The Diagnostic Yield of Stool Cultures.

Authors:  Tamar Berger; Odil Giladi; Dafna Yahav; Haim Ben-Zvi; Oren Pasvolsky; Liat Shargian-Alon; Ofir Wolach; Uri Rozovski; Pia Raanani; Moshe Yeshurun
Journal:  Infect Dis Ther       Date:  2021-03-04

2.  Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.

Authors:  Andrew J Ullmann; Martin Schmidt-Hieber; Hartmut Bertz; Werner J Heinz; Michael Kiehl; William Krüger; Sabine Mousset; Stefan Neuburger; Silke Neumann; Olaf Penack; Gerda Silling; Jörg Janne Vehreschild; Hermann Einsele; Georg Maschmeyer
Journal:  Ann Hematol       Date:  2016-06-24       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.